Argent BioPharma Limited
RGT.L · LSE
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £1 | £3 | £0 | £1 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £0 | £0 | £1 | £1 |
| Inventory | £1 | £1 | £1 | £1 |
| Other Curr. Assets | £1 | £1 | £0 | £0 |
| Total Curr. Assets | £3 | £5 | £3 | £3 |
| Property Plant & Equip (Net) | £7 | £4 | £7 | £5 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £1 | £1 | £0 | £1 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £0 | £0 | £0 |
| Total NC Assets | £8 | £4 | £7 | £6 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £11 | £9 | £10 | £9 |
| Liabilities | – | – | – | – |
| Payables | £1 | £1 | £2 | £2 |
| Short-Term Debt | £0 | £5 | £0 | £4 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £1 | £0 | £1 | £0 |
| Other Curr. Liab. | £10 | £0 | £10 | £0 |
| Total Curr. Liab. | £12 | £7 | £13 | £7 |
| LT Debt | £1 | £0 | £0 | £1 |
| Deferred Rev, NC | £4 | £0 | £4 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £2 | £0 | £2 |
| Total NC Liab. | £4 | £2 | £5 | £4 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £1 | £0 | £1 | £1 |
| Total Liabilities | £17 | £9 | £18 | £10 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £123 | £64 | £104 | £56 |
| Retained Earnings | -£130 | -£67 | -£119 | -£62 |
| AOCI | £1 | £5 | £8 | £4 |
| Other Equity | £1 | £0 | £0 | £0 |
| Total Equity | -£5 | £1 | -£7 | -£1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -£1 | -£0 | -£1 | -£0 |
| Total Liab. & Tot. Equity | £11 | £9 | £10 | £9 |
| Net Debt | £0 | £2 | £0 | £5 |